San Diego, 92121, CA,
United States
GenomeDx Biosciences Technographics
GenomeDx Biosciences Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by GenomeDx Biosciences and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 70 GenomeDx Biosciences employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that GenomeDx Biosciences has purchased the following applications: Oracle NetSuite ERP for ERP Financial in 2015, Microsoft 365 for Collaboration in 2015, Exclaimer Cloud Signatures for Office 365 for Digital Signing in 2017 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems GenomeDx Biosciences is running and its propensity to invest more and deepen its relationship with Oracle , Microsoft , Exclaimer or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing GenomeDx Biosciences revenues, which have grown to $7.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for GenomeDx Biosciences intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
GenomeDx Biosciences Tech Stack and Enterprise Applications
GenomeDx Biosciences ERP
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Oracle | Legacy | Oracle NetSuite ERP | ERP Financial | ERP | n/a | 2015 | 2015 |
In 2015, GenomeDx Biosciences implemented Oracle NetSuite ERP as its ERP Financial solution for core finance and accounting functions. The 70-employee United States consumer packaged goods company configured Oracle NetSuite ERP to centralize transaction recording and reporting across its finance organization.
Deployment used a cloud SaaS instance of Oracle NetSuite ERP provisioned with core financial modules including general ledger, accounts payable, accounts receivable, cash management, fixed assets, and financial reporting. The implementation emphasized chart of accounts rationalization, role based access control, audit trail enabled transaction posting, and month end close workflows to standardize accounting processes across the finance and accounting departments.
|
GenomeDx Biosciences Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2015 | 2015 |
In 2015 GenomeDx Biosciences implemented Microsoft 365 as its Collaboration platform to centralize email, document collaboration, and real time team communication across the organization. The deployment is presented on the company website and reflects a cloud hosted Microsoft 365 tenant with centralized administration and identity controls scaled for a 70 person company, providing the core Collaboration services used across the business.
The Microsoft 365 implementation includes standard Collaboration modules such as Exchange Online for corporate email, SharePoint Online for intranet and shared document libraries, OneDrive for Business for user file sync, and Microsoft Teams for persistent chat and meetings. Operational coverage spans product development, marketing, sales, and administrative functions, with governance implemented through centralized user provisioning, admin role separation, and baseline compliance and retention settings to manage document lifecycle and access control.
|
GenomeDx Biosciences Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Exclaimer | Legacy | Exclaimer Cloud Signatures for Office 365 | Digital Signing | Content Management | n/a | 2017 | 2017 |
In 2017, GenomeDx Biosciences implemented Exclaimer Cloud Signatures for Office 365. GenomeDx deployed Exclaimer Cloud Signatures for Office 365 as a Digital Signing solution to centralize corporate email signature management and enforce consistent branded outbound messaging across its Office 365 tenant, with the implementation visible in the public site source.
The cloud-hosted Exclaimer implementation integrates directly with Office 365 mail flow and user accounts to apply centrally managed signature templates, aligning marketing and customer-facing functions under a single brand standard. Administration and policy control are handled at the tenant level to provide organization-wide signature governance for a company of approximately 70 employees, using Exclaimer Cloud Signatures for Office 365 to connect Digital Signing capabilities to email and branding workflows.
|
GenomeDx Biosciences CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Marketing Automation | CRM |
|
2017 | 2017 |
|
|
|
|
|
Marketing Automation | CRM |
|
2017 | 2017 |
|
|
|
|
|
Sales Automation, CRM, Sales Engagement | CRM |
|
2021 | 2021 |
|
GenomeDx Biosciences IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2013 | 2013 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
IT Decision Makers and Key Stakeholders at GenomeDx Biosciences
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| Chief Operating Officer | CXO | Finance | ||||
| President & CSO, Director | Director | Finance | ||||
| VP of Sales and Support | VP | Sales |
Apps Being Evaluated by GenomeDx Biosciences Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||